Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration

Crit Care. 2019 Apr 26;23(1):145. doi: 10.1186/s13054-019-2434-5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cephalosporins / administration & dosage*
  • Cephalosporins / pharmacology
  • Cephalosporins / therapeutic use
  • Critical Illness / therapy
  • Dose-Response Relationship, Drug*
  • Hemofiltration / methods
  • Humans
  • Male
  • Tazobactam / administration & dosage*
  • Tazobactam / pharmacology
  • Tazobactam / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • ceftolozane, tazobactam drug combination
  • Tazobactam